Patents by Inventor Luke Alphey
Luke Alphey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250163403Abstract: The present invention relates to a method of generating a plurality of engineered subpopulations each comprising a gene drive.Type: ApplicationFiled: May 1, 2020Publication date: May 22, 2025Inventors: Luke Alphey, Tim Harvey-samuel, Matt Edgington
-
Publication number: 20240016132Abstract: Two or more conditional, dominant, lethal gene expression systems provide high levels of penetrance in insects. Lethality is induced at an earlier stage of development and the risk of biochemical resistance is reduced, as compared to a single insect conditional, dominant, lethal gene expression system. The invention is useful for the control of insect populations.Type: ApplicationFiled: July 14, 2023Publication date: January 18, 2024Applicant: Oxitec LimitedInventors: Martha Koukidou, Luke Alphey, Simon Warner
-
Patent number: 11827876Abstract: The invention provides a splice control module for sex-specific splicing and expression of a gene of interest. In certain embodiments, a dsx-based splice control module is used to express a lethal gene in an insect that is spliced in a sex-specific manner to impart lethality to female insects but not male insects.Type: GrantFiled: August 9, 2017Date of Patent: November 28, 2023Assignee: OXITEC LTD.Inventors: Luke Alphey, Tarig Dafa'alla, Amandine Collado, Simon Warner, Kelly Matzen, Sian Spinner
-
Patent number: 11737436Abstract: Two or more conditional, dominant, lethal gene expression systems provide high levels of penetrance in insects. Lethality is induced at an earlier stage of development and the risk of biochemical resistance is reduced, as compared to a single insect conditional, dominant, lethal gene expression system. The invention is useful for the control of insect populations.Type: GrantFiled: August 19, 2020Date of Patent: August 29, 2023Assignee: Oxitec LimitedInventors: Martha Koukidou, Luke Alphey, Simon Warner
-
Publication number: 20210137083Abstract: Two or more conditional, dominant, lethal gene expression systems provide high levels of penetrance in insects. Lethality is induced at an earlier stage of development and the risk of biochemical resistance is reduced, as compared to a single insect conditional, dominant, lethal gene expression system. The invention is useful for the control of insect populations.Type: ApplicationFiled: August 19, 2020Publication date: May 13, 2021Inventors: Martha Koukidou, Luke Alphey, Simon Warner
-
Patent number: 10941416Abstract: A polynucleotide expression system is provided that is capable of alternative splicing of RNA transcripts of a polynucleotide sequence to be expressed in an organism.Type: GrantFiled: May 1, 2018Date of Patent: March 9, 2021Assignee: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 10844402Abstract: A gene expression system is provided. The system comprises at least one coding sequence to be expressed in an organism, and at least one promoter operably linked thereto. It further comprises at least one splice control sequence which, in cooperation with a spliceosome, mediates alternative splicing of RNA transcripts of the coding sequence. The mediation of alternative splicing is in a sex-specific, stage-specific, germline-specific and tissue-specific manner.Type: GrantFiled: July 13, 2018Date of Patent: November 24, 2020Assignee: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 10426147Abstract: Provided is a gene expression system, suitable for expression in an insect, comprising an insect muscle actin promoter operably linked to a marker gene, which overcomes or ameliorates one or more of: cost of rearing; amount of handling; errors in identification due to human error or loss of marker by the insect; and health concerns related to the effects of marker powders on workers in mass rearing facilities.Type: GrantFiled: June 23, 2017Date of Patent: October 1, 2019Assignee: Oxitec LimitedInventors: Martha Koukidou, Sarah Scaife, Luke Alphey
-
Publication number: 20180312870Abstract: A gene expression system is provided. The system comprises at least one coding sequence to be expressed in an organism, and at least one promoter operably linked thereto. It further comprises at least one splice control sequence which, in cooperation with a spliceosome, mediates alternative splicing of RNA transcripts of the coding sequence. The mediation of alternative splicing is in a sex-specific, stage-specific, germline-specific and tissue-specific manner.Type: ApplicationFiled: July 13, 2018Publication date: November 1, 2018Inventor: Luke Alphey
-
Patent number: 10059961Abstract: A gene expression system is provided. The system comprises at least one coding sequence to be expressed in an organism, and at least one promoter operably linked thereto. It further comprises at least one splice control sequence which, in cooperation with a spliceosome, mediates alternative splicing of RNA transcripts of the coding sequence. The mediation of alternative splicing is in a sex-specific, stage-specific, germline-specific and tissue-specific manner.Type: GrantFiled: August 28, 2015Date of Patent: August 28, 2018Assignee: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 9970025Abstract: A polynucleotide expression system is provided that is capable of alternative splicing of RNA transcripts of a polynucleotide sequence to be expressed in an organism.Type: GrantFiled: January 8, 2016Date of Patent: May 15, 2018Assignee: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 9487801Abstract: Provided is an arthropod male germline gene expression system suitable for conditional expression of an effector gene in an Arthropod male germline. The system comprises a first expression unit comprising an effector gene and a promoter therefor operably linked thereto; and a second expression unit. Said second unit comprises a coding sequence for a transcription factor and an upstream regulatory element operably linked thereto, the transcription factor being capable of acting upon the promoter in the first expression unit to drive expression of the effector gene. The upstream regulatory element includes a promoter for the transcription factor; and a 5? UTR adjacent a start site for the transcription factor coding sequence. The upstream regulatory element driving sufficient expression of the transcription factor such that the transcription factor protein in turn drives transcription of the effector gene before meiosis.Type: GrantFiled: March 5, 2013Date of Patent: November 8, 2016Assignee: OXITEC LIMITEDInventor: Luke Alphey
-
Publication number: 20160122780Abstract: A polynucleotide expression system is provided that is capable of alternative splicing of RNA transcripts of a polynucleotide sequence to be expressed in an organism.Type: ApplicationFiled: January 8, 2016Publication date: May 5, 2016Applicant: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 9180464Abstract: There is provided an apparatus for sorting arthropod larvae and pupae and in particular, although not necessarily, to sorting arthropod pupae on the basis of size, especially in mosquitoes. The apparatus can contain two parallel bars pivotally mounted in a frame such that the distance between the bars is adjustable. Insect larvae and pupae may be inserted into a chamber with one side formed by the grid of bars and inserted into water to separate the different forms.Type: GrantFiled: September 19, 2014Date of Patent: November 10, 2015Assignee: OXITEC LIMITEDInventors: Derric David Nimmo, Luke Alphey
-
Patent number: 9133477Abstract: A gene expression system is provided. The system comprises at least one coding sequence to be expressed in an organism, and at least one promoter operably linked thereto. It further comprises at least one splice control sequence which, in cooperation with a spliceosome, mediates alternative splicing of RNA transcripts of the coding sequence. The mediation of alternative splicing is in a sex-specific, stage-specific, germline-specific and tissue-specific manner.Type: GrantFiled: February 10, 2006Date of Patent: September 15, 2015Assignee: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 9125388Abstract: The invention relates to a non-human multicellular organism carrying a dominant lethal genetic system, the lethal effect of which is conditional, wherein the lethal effect of the lethal system occurs in the natural environment of the organism.Type: GrantFiled: July 15, 2013Date of Patent: September 8, 2015Assignee: Isis Innovation LimitedInventors: Luke Alphey, Dean Thomas
-
Patent number: 9121036Abstract: Promoters active in insects can be enhanced by positive feedback mechanisms and associated with repressible lethal effects.Type: GrantFiled: July 28, 2004Date of Patent: September 1, 2015Assignee: Oxitec LimitedInventor: Luke Alphey
-
Publication number: 20150143552Abstract: Provided is an arthropod male germline gene expression system suitable for conditional expression of an effector gene in an Arthropod male germline. The system comprises a first expression unit comprising an effector gene and a promoter therefor operably linked thereto; and a second expression unit. Said second unit comprises a coding sequence for a transcription factor and an upstream regulatory element operably linked thereto, the transcription factor being capable of acting upon the promoter in the first expression unit to drive expression of the effector gene. The upstream regulatory element includes a promoter for the transcription factor; and a 5? UTR adjacent a start site for the transcription factor coding sequence. The upstream regulatory element driving sufficient expression of the transcription factor such that the transcription factor protein in turn drives transcription of the effector gene before meiosis.Type: ApplicationFiled: March 5, 2013Publication date: May 21, 2015Inventor: Luke Alphey
-
Patent number: 8124404Abstract: There is provided a transposable element comprising at least four inverted repeats, at least two of which are each inverted in relation to another, the element comprising DNA for insertion into a host genome, the DNA being located between two pairs of opposing repeats excisable by a transposase in situ to leave said DNA without flanking transposon-derived repeats in the host genome. Also provided is a transposable element comprising at least three inverted repeats, at least one of which is inverted in relation to the others, wherein at least one non-terminal repeat is a minimal repeat. Both these elements allow for greater efficiency of insertion of nucleotide sequences into the genome.Type: GrantFiled: July 1, 2004Date of Patent: February 28, 2012Assignee: Oxitec LimitedInventor: Luke Alphey
-
Patent number: 7998475Abstract: Undesirable genetic traits, such as resistance to toxin, can be inhibited or reversed by introducing sexually compatible individuals substantially homozygous for the sensitive allele, such as the wild type, into the target population.Type: GrantFiled: May 12, 2004Date of Patent: August 16, 2011Assignee: Oxitec LimitedInventor: Luke Alphey